Two Sigma Investments’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.95M | Buy |
159,163
+11,543
| +8% | +$504K | 0.01% | 1004 |
|
|
2025
Q1 | $4.04M | Sell |
147,620
-26,133
| -15% | -$715K | 0.01% | 1203 |
|
|
2024
Q4 | $6.99M | Sell |
173,753
-96,282
| -36% | -$3.87M | 0.02% | 878 |
|
|
2024
Q3 | $12.8M | Sell |
270,035
-78,883
| -23% | -$3.73M | 0.03% | 621 |
|
|
2024
Q2 | $10.4M | Buy |
348,918
+221,172
| +173% | +$6.6M | 0.02% | 651 |
|
|
2024
Q1 | $5.14M | Sell |
127,746
-4,818
| -4% | -$194K | 0.01% | 910 |
|
|
2023
Q4 | $3.38M | Sell |
132,564
-94,675
| -42% | -$2.41M | 0.01% | 1136 |
|
|
2023
Q3 | $3.16M | Buy |
227,239
+39,935
| +21% | +$555K | 0.01% | 1069 |
|
|
2023
Q2 | $4.31M | Sell |
187,304
-55,208
| -23% | -$1.27M | 0.01% | 935 |
|
|
2023
Q1 | $7.19M | Buy |
242,512
+123,465
| +104% | +$3.66M | 0.02% | 689 |
|
|
2022
Q4 | $2.97M | Sell |
119,047
-10,324
| -8% | -$258K | 0.01% | 1068 |
|
|
2022
Q3 | $2.82M | Sell |
129,371
-14,586
| -10% | -$317K | 0.01% | 965 |
|
|
2022
Q2 | $2.84M | Buy |
143,957
+87,633
| +156% | +$1.73M | 0.01% | 971 |
|
|
2022
Q1 | $2.38M | Buy |
56,324
+49,302
| +702% | +$2.09M | 0.01% | 1242 |
|
|
2021
Q4 | $446K | Buy |
+7,022
| New | +$446K | ﹤0.01% | 2034 |
|
|
2021
Q2 | – | Sell |
-10,665
| Closed | -$414K | – | 2664 |
|
|
2021
Q1 | $414K | Buy |
+10,665
| New | +$414K | ﹤0.01% | 1941 |
|